EUVIMEDEUVIMED entdecken
Crossref

Oral Colon‐ and Mitochondria‐Targeted Nanoparticles Alleviate Ulcerative Colitis by Reeducating Macrophage Polarization via SIRT3/FOXO3a‐Mediated Mitochondrial Restoration

Ruya Mei iD, Rong Zhang, Zhengyang Li, Jie Luo, Xinyue Zhang, Tong Zhang, Guanglei Lv, Juhua Zhang, Bingqing Liang, Yuzhong Yan iD

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Ruya Mei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Henan Medical University (formerly known as Xinxiang Medical University), Xinxiang, Henan, People's Republic of China. Hauptthemen laut MEDLINE: Forkhead Box Protein O3, Colitis, Ulcerative, Mitochondria, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Pudong Health Bureau, Shanghai, Construction Project of Shanghai Key Laboratory of Molecular Imaging, Science and Technology Commission of Pudong New Area, Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Mitochondrial dysfunction in macrophages drives pro‐inflammatory M1 polarization in ulcerative colitis (UC). We developed a colon‐targeted, mitochondria‐directed nanoplatform (KSF@SS31@S100Ns) to restore mitochondrial fitness and alleviate UC.

Methods

Kaempferol‐loaded silk fibroin (SF) nanoparticles were conjugated with SS‐31 peptide and coated with pH‐sensitive Eudragit S100. Physicochemical properties, release profile, and uptake were characterized. Mitochondrial function, macrophage polarization, and SIRT3/FOXO3a signaling were assessed in LPS‐stimulated RAW264.7 cells. Efficacy and mechanisms were evaluated in a DSS‐induced colitis mouse model.

Results

Nanoparticles showed uniform size (~307 nm), high stability, and pH‐dependent release. SS‐31 enhanced macrophage uptake and mitochondrial localization. In vitro, KSF@SS31Ns restored mitochondrial membrane potential and ATP, reduced ROS, promoted mitophagy, and shifted macrophages toward the M2 phenotype via SIRT3/FOXO3a activation. In vivo, oral KSF@SS31@S100Ns accumulated in inflamed colons, reduced disease severity, suppressed pro‐inflammatory cytokines, elevated IL‐10, restored tight‐junction proteins, and increased M2 macrophages.

Conclusions

KSF@SS31@S100Ns effectively treats experimental colitis by restoring mitochondrial homeostasis, reprogramming macrophage polarization, and repairing the intestinal barrier, offering a translational nanotherapeutic strategy for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein O3Colitis, UlcerativeMitochondriaNanoparticlesMacrophagesSirtuin 3ColonAnimalsDisease Models, AnimalMiceAdministration, OralRAW 264.7 CellsPolymethacrylic AcidsMice, Inbred C57BLMale

Substanzen

Forkhead Box Protein O3FoxO3 protein, mouseSirtuin 3Sirt3 protein, mousePolymethacrylic Acids

Autor:innen und Institutionen

  • Graduate School, Henan Medical University (formerly known as Xinxiang Medical University), Xinxiang, Henan, People's Republic of China.
  • Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Zhoupu Hospital, Shanghai, People's Republic of China.
  • Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, People's Republic of China.
  • Graduate School, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.
  • Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Postgraduate School, University of Shanghai for Science and Technology, Shanghai, People's Republic of China.

ORCID-Profile: Ruya Mei, Yuzhong Yan

Förderung

  • Pudong Health Bureau, Shanghai
  • Construction Project of Shanghai Key Laboratory of Molecular Imaging
  • Science and Technology Commission of Pudong New Area, Shanghai

Zitieren

APA

Mei, R., Zhang, R., Li, Z., Luo, J., Zhang, X., Zhang, T., Lv, G., Zhang, J., Liang, B., & Yan, Y. (2026). Oral Colon‐ and Mitochondria‐Targeted Nanoparticles Alleviate Ulcerative Colitis by Reeducating Macrophage Polarization via SIRT3/FOXO3a‐Mediated Mitochondrial Restoration. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70668

Vancouver

Mei R, Zhang R, Li Z, Luo J, Zhang X, Zhang T, et al. Oral Colon‐ and Mitochondria‐Targeted Nanoparticles Alleviate Ulcerative Colitis by Reeducating Macrophage Polarization via SIRT3/FOXO3a‐Mediated Mitochondrial Restoration. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70668

BibTeX
@article{Mei2026,
  author = {Mei, Ruya and Zhang, Rong and Li, Zhengyang and Luo, Jie and Zhang, Xinyue and Zhang, Tong and Lv, Guanglei and Zhang, Juhua and Liang, Bingqing and Yan, Yuzhong},
  title = {Oral Colon‐ and Mitochondria‐Targeted Nanoparticles Alleviate Ulcerative Colitis by Reeducating Macrophage Polarization via SIRT3/FOXO3a‐Mediated Mitochondrial Restoration},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70668}
}
Kostenlos starten →